< Back to All Resources
The objectives of this webinar are to describe diagnostic tests that are used prenatally and postnatally to identify NAS, and discuss practice based implications of legalities in drug screening and testing for prenatal drug exposure. Refer to the Ohio Perinatal Quality Collaborative for more information and a link to this recording: https://opqc.net/patients-providers/%20NAS
External Link
https://opqc.net/sites/bmidrupalpopqc.chmcres.cchmc.org/files/Webinar%20Series/NAS%20Level%20I%20ID%20of%20Substance%20Use%20in%20Pregnancy-%20Legalities%20and%20Practicalities.pdf
Related Topics
- Behavioral Health
- Child Welfare
- Children 0-5
- Medical Care
- Clinical Tools